In contrast, Kelley et al. generated receptor-selective mutants of TRAIL, with three to six ligand amino acid substitutions [17], and found DR5 to be more important for apoptotic signaling than DR4 in cancer cells expressing both receptors (including colon cancer cells). The gene discussed is TNFSF10; the disease is malignant colon neoplasm.